Molecular-based recursive partitioning analysis model for glioblastoma in the temozolomide era: a correlative analysis based on NRG oncology RTOG 0525

EH Bell, SL Pugh, JP McElroy, MR Gilbert… - JAMA …, 2017 - jamanetwork.com
Importance There is a need for a more refined, molecularly based classification model for
glioblastoma (GBM) in the temozolomide era. Objective To refine the existing clinically …
被引用次数：91 相关文章

[引用][C] Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era: A Correlative Analysis Based on NRG Oncology RTOG …

EH Bell, SL Pugh, JP McElroy… - JAMA …, 2017 - baptisthealth.elsevierpure.com
Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the
Temozolomide Era: A Correlative Analysis Based on NRG Oncology RTOG 0525 — Baptist …

Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era: A Correlative Analysis Based on NRG Oncology RTOG 0525.

EH Bell, SL Pugh, JP McElroy, MR Gilbert… - JAMA …, 2017 - europepmc.org
Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide
Era: A Correlative Analysis Based on NRG Oncology RTOG 0525. - Abstract - Europe PMC …

Molecular-based recursive partitioning analysis model for glioblastoma in the temozolomide era a correlative analysis based on nrg oncology RTOG 0525

EH Bell, SL Pugh, JP McElroy, MR Gilbert… - JAMA …, 2017 - scholars.northwestern.edu
IMPORTANCE: There is a need for a more refined, molecularly based classification model
for glioblastoma (GBM) in the temozolomide era. OBJECTIVE: To refine the existing clinically …

Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era: A Correlative Analysis Based on NRG Oncology RTOG 0525.

EH Bell, SL Pugh, JP McElroy, MR Gilbert, M Mehta… - JAMA oncology, 2017 - folia.unifr.ch
Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide
Era: A Correlative Analysis Based on NRG Oncology RTOG 0525. SONAR logo Log in Sign …

Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era: A Correlative Analysis Based on NRG Oncology RTOG 0525.

EH Bell, SL Pugh, JP McElroy, MR Gilbert, M Mehta… - 2017 - jdc.jefferson.edu
Importance: There is a need for a more refined, molecularly based classification model for
glioblastoma (GBM) in the temozolomide era. Objective: To refine the existing clinically …

Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era: A Correlative Analysis Based on NRG Oncology RTOG 0525.

EH Bell, SL Pugh, JP McElroy, MR Gilbert, M Mehta… - JAMA …, 2017 - orbi.uliege.be
Importance: There is a need for a more refined, molecularly based classification model for
glioblastoma (GBM) in the temozolomide era. Objective: To refine the existing clinically …

Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era: A Correlative Analysis Based on NRG Oncology RTOG 0525.

EH Bell, SL Pugh, JP McElroy, MR Gilbert, M Mehta… - JAMA oncology, 2017 - sonar.ch
Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide
Era: A Correlative Analysis Based on NRG Oncology RTOG 0525. SONAR logo Log in Sign …
[PDF] researchgate.net

[PDF][PDF] Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era A Correlative Analysis Based on NRG Oncology RTOG 0525

EH Bell, SL Pugh, JP McElroy, MR Gilbert, M Mehta… - JAMA, 2017 - researchgate.net
OBJECTIVE To refine the existing clinically based recursive partitioning analysis (RPA)
model by incorporating molecular variables. DESIGN, SETTING, AND PARTICIPANTS NRG …

Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era: A Correlative Analysis Based on NRG Oncology RTOG 0525

EH Bell, SL Pugh, JP McElroy, MR Gilbert, M Mehta… - 2017 - pubmed.ncbi.nlm.nih.gov
Importance There is a need for a more refined, molecularly based classification model for
glioblastoma (GBM) in the temozolomide era. Objective To refine the existing clinically …